§ 18–506
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health-Gen. § 18-506 (2026)
Title 18. Disease Prevention
Subtitle 5. Sickle Cell Anemia
§ 18–506LinkCopy Citation
(a)
In this section, “Steering Committee” means the Statewide Steering Committee on Sickle Cell Disease.
(b)
There is a Statewide Steering Committee on Sickle Cell Disease.
(c)
The Steering Committee shall include representatives from:
(1)
Local and national groups that advocate for individuals with sickle cell disease;
(2)
Interest and support groups for individuals with sickle cell disease;
(3)
Community and consumer groups;
(4)
Academic and private clinical settings with knowledge and experience caring for adults with sickle cell disease;
(5)
Area hospitals caring for individuals with sickle cell disease; and
(6)
Pediatric clinics that care for children with sickle cell disease.
(d)
The Steering Committee shall:
(1)
Establish institution and community partnerships;
(2)
Establish a statewide network of stakeholders who care for individuals with sickle cell disease;
(3)
Educate individuals with sickle cell disease, the public, and health care providers about the State options for care of sickle cell disease; and
(4)
Identify funding sources for implementing or supporting the actions, studies, policies, regulations, or laws recommended by the Steering Committee, including funding from:
(i)
State, federal, and local government sources; and
(ii)
Private sources.